‘Fycompa’ turned in the registration of the health insurance benefit, giving an advance notice as a new mechanism of epilepsy treatment
A prescription option for a new mechanism of epilepsy treatment is going to be added.
According to the industry concerned on the 30th, Eisai has turned in a registration application of the health insurance benefit for the domestically approved epilepsy treating new drug, ‘Fycompa(perampanel).’
...Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
